Arbutus Biopharma Corp Assets, Fair Value Disclosure
Arbutus Biopharma Corp (ABUS) had Assets, Fair Value Disclosure of $91.47 million as of 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2026-03-23
- 2012-12-31: Assets, Fair Value Disclosure 46.79M CAD.
- 2011-12-31: Assets, Fair Value Disclosure 9.18M CAD.
CAD
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2012-12-31 | 46.79M CAD 20-F · filed 2013-03-27 |
| 2011-12-31 | 9.18M CAD 20-F · filed 2013-03-27 |
USD
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2025-12-31 | $91.47M 10-K · filed 2026-03-23 |
| 2024-12-31 | $122.62M 10-K · filed 2026-03-23 |
| 2018-03-31 | $172.54M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $138.95M 10-Q · filed 2018-05-04 |
| 2017-09-30 | $100.78M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $115.61M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $122.98M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $143.16M 10-K · filed 2018-03-16 |
| 2016-09-30 | $149.68M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $155.18M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $182.67M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $191.37M 10-K · filed 2017-03-22 |
| 2015-09-30 | $206.14M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $217.22M 10-Q · filed 2015-08-07 |
| 2014-12-31 | $112.16M 10-K · filed 2016-03-09 |
| 2014-09-30 | $120.47M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $129.46M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $12.82M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $68.72M 10-K · filed 2014-03-28 |
| 2012-12-31 | $47.02M 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |